Free tool
FAERS Monitor: Medrol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 011153 or its brand name (Medrol, Methylprednisolone). Reports on generic versions are filed under their own applications.
Reports
124,181
Serious
110,690
89% of reports
Hospitalization
51,149
Death reported
19,405
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use18,660
- drug ineffective14,392
- fatigue6,387
- nausea6,032
- pain5,898
- headache5,777
- pneumonia5,729
- pyrexia5,721
- dyspnoea5,449
- arthralgia5,351
- diarrhoea5,294
- condition aggravated5,023
- product use in unapproved indication4,933
- rash4,229
- hypertension4,196
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 825 |
| 2005 | 878 |
| 2006 | 944 |
| 2007 | 826 |
| 2008 | 1,124 |
| 2009 | 1,138 |
| 2010 | 1,855 |
| 2011 | 2,377 |
| 2012 | 2,922 |
| 2013 | 2,671 |
| 2014 | 3,195 |
| 2015 | 3,989 |
| 2016 | 4,632 |
| 2017 | 5,753 |
| 2018 | 8,014 |
| 2019 | 9,407 |
| 2020 | 12,161 |
| 2021 | 11,536 |
| 2022 | 11,383 |
| 2023 | 10,448 |
| 2024 | 10,700 |
| 2025 | 10,662 |
| 2026 | 6,733 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,929,978 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| off label useSignal | 18,660 | 3.7 | 3.6 | 36,945 |
| product use in unapproved indicationSignal | 4,933 | 3.4 | 3.3 | 8,372 |
| hypertensionSignal | 4,196 | 3.4 | 3.3 | 7,048 |
| pneumoniaSignal | 5,729 | 3.0 | 3.0 | 7,787 |
| pyrexiaSignal | 5,721 | 2.8 | 2.8 | 6,771 |
| condition aggravatedSignal | 5,023 | 2.8 | 2.8 | 5,923 |
| arthralgiaSignal | 5,351 | 2.2 | 2.1 | 3,505 |
| drug ineffective | 14,392 | 1.9 | 1.8 | 6,027 |
| rash | 4,229 | 1.6 | 1.6 | 1,093 |
| dyspnoea | 5,449 | 1.6 | 1.6 | 1,372 |
| pain | 5,898 | 1.6 | 1.6 | 1,473 |
| headache | 5,777 | 1.6 | 1.5 | 1,206 |
| fatigue | 6,387 | 1.4 | 1.4 | 728 |
| diarrhoea | 5,294 | 1.4 | 1.4 | 598 |
| nausea | 6,032 | 1.3 | 1.3 | 413 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.